
Amarin Corporation Investor Relations Material
Latest events

Q4 2024
Amarin Corporation
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Amarin Corporation plc
Access all reports
Amarin Corporation plc is a biopharmaceutical company focused on developing and commercializing therapies for cardiovascular health. The company's primary product is an omega-3-based prescription therapy designed to reduce cardiovascular risk in patients with elevated triglyceride levels. Amarin's research and development efforts center on addressing unmet needs in cardiovascular care through innovative lipid management treatments. The company operates globally, with a focus on expanding its product offerings and advancing cardiovascular treatment options. The company is headquartered in Dublin, Ireland, and its shares are listed on the Nasdaq.
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
AMRN
Country
🇺🇸 United States